APLS
NASDAQStockApellis Pharmaceuticals, Inc.
$18.69+0.30 (+1.63%)
52-Week Range
$16.36
$30.05
Key Stats
Market Cap
2.4B
P/E Ratio
60.29
Dividend Yield
—
Beta
0.29
Volume
785.7K
Avg Volume
2.0M
Performance
1M
-16.60%
3M
-25.12%
6M
-24.60%
YTD
-28.89%
1Y
-25.43%
3Y
-71.94%
5Y
-60.96%
Price Chart
ETF Exposure
APLS is held by 133 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| JFWD | Jacob Forward ETF | 2.59% |
| SBIO | ALPS Medical Breakthroughs ETF | 1.54% |
| FXH | First Trust Health Care AlphaDEX Fund | 1.42% |
| PINK | Simplify Health Care ETF | 1.36% |
| PSCH | Invesco S&P SmallCap Health Care ETF | 1.21% |
| BBP | Virtus Biotech ETF | 1.16% |
| CURE.AX | Global X - S&P Biotech ETF | 0.69% |
| XBI | State Street SPDR S&P Biotech ETF | 0.69% |
| MRND | IQ U.S. Mid Cap R&D Leaders ETF | 0.68% |
| JSMD | Janus Henderson Small/Mid Cap Growth Alpha ETF | 0.51% |
| RZG | Invesco S&P SmallCap 600 Pure Growth ETF | 0.42% |
| FYC | First Trust Small Cap Growth AlphaDEX Fund | 0.39% |
| FVI | First Trust Total US Market AlphaDEX ETF | 0.30% |
| VIOG | Vanguard S&P Small-Cap 600 Growth ETF | 0.29% |
| IJT | iShares S&P Small-Cap 600 Growth ETF | 0.26% |
| SLYG | State Street SPDR S&P 600 Small Cap Growth ETF | 0.25% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.19% |
| SBIO.L | Invesco NASDAQ Biotech UCITS ETF | 0.19% |
| 2B77.DE | iShares Ageing Population UCITS ETF | 0.18% |
| STLG | iShares Factors US Growth Style ETF | 0.18% |
| IBB | iShares Biotechnology ETF | 0.18% |
| LABU | Direxion Daily S&P Biotech Bull 3X ETF | 0.15% |
| VIOO | Vanguard S&P Small-Cap 600 ETF | 0.15% |
| PWS | Pacer WealthShield ETF | 0.14% |
| FYX | First Trust Small Cap Core AlphaDEX Fund | 0.14% |
| IJR | iShares Core S&P Small-Cap ETF | 0.13% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.13% |
| IDP6.L | iShares S&P SmallCap 600 UCITS ETF | 0.13% |
| IJR.AX | iShares S&P Small-Cap ETF | 0.13% |
| IUS3.DE | iShares S&P SmallCap 600 UCITS ETF | 0.13% |
| XSMC.TO | iShares S&P U.S. Small-Cap Index ETF | 0.13% |
| XSMH.TO | iShares S&P U.S. Small-Cap Index ETF (CAD-Hedged) | 0.13% |
| SPSM | State Street SPDR Portfolio S&P 600 Small Cap ETF | 0.13% |
| RFLR | Innovator U.S. Small Cap Managed Floor ETF | 0.12% |
| STXK | Strive Small-Cap ETF | 0.10% |
| PRFZ | Invesco RAFI US 1500 Small-Mid ETF | 0.10% |
| SAA | ProShares - Ultra SmallCap600 | 0.09% |
| BBSC | JPMorgan BetaBuilders U.S. Small Cap Equity ETF | 0.09% |
| BKSE | BNY Mellon US Small Cap Core Equity ETF | 0.09% |
| FAD | First Trust Multi Cap Growth AlphaDEX Fund | 0.08% |
| KBFR | Innovator U.S. Small Cap Managed 10 Buffer ETF | 0.08% |
| VBK | Vanguard Small-Cap Growth ETF | 0.07% |
| IWP | iShares Russell Mid-Cap Growth ETF | 0.07% |
| STSB | iShares Factors US Small Blend Style ETF | 0.07% |
| EES | WisdomTree U.S. SmallCap Fund | 0.07% |
| EQAL | Invesco Russell 1000 Equal Weight ETF | 0.07% |
| ISCG | iShares Morningstar Small-Cap Growth ETF | 0.06% |
| JKK | iShares Morningstar Small-Cap Growth ETF | 0.06% |
| SCHA | Schwab U.S. Small-Cap ETF | 0.05% |
| DFAS | Dimensional - US Small Cap ETF | 0.04% |
Page 1 of 3Next
About APLS ETF Exposure
Apellis Pharmaceuticals, Inc. (APLS) is held by 133 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 2.4B, APLS is a widely held institutional stock. The stock currently trades at $18.69. Investors can gain exposure to APLS through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold APLS, sorted by portfolio weight.